A European study proposes to exploit the involvement of transglutaminase enzymes in disease to develop novel diagnostic methods and therapies. Focusing on coeliac disease and neurodegenerative disorders, scientists of the TRANSCOM project are screening an array of enzyme inhibitors and protective compounds.
Further information: cordis.europa.eu